Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19

Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.

Authors

Netanel A Horowitz^{1

2}, Benjamin Brenner^{1

2

3}

Affiliations

¹ Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
² The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
³ Department of Obstetrics and Gynaecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

No abstract available

Publication types

Review

MeSH terms

Anticoagulants / therapeutic use
Betacoronavirus*
COVID-19
Coronavirus Infections / blood*
Coronavirus Infections / complications
Cytokine Release Syndrome / blood
Cytokine Release Syndrome / etiology
Endothelium, Vascular / physiopathology
Extracellular Traps
Extracellular Vesicles
Fibrinolytic Agents / therapeutic use
Hemostasis*
Humans
Intermittent Pneumatic Compression Devices
Neoplasms / blood*
Neoplasms / complications
Pandemics*
Pneumonia, Viral / blood*
Pneumonia, Viral / complications
Risk
SARS-CoV-2
Thrombophilia / blood
Thrombophilia / drug therapy
Thrombophilia / etiology*
Thromboplastin / physiology
Thrombosis / blood
Thrombosis / etiology*
Venous Thromboembolism / blood
Venous Thromboembolism / etiology
Venous Thromboembolism / prevention & control

Substances

Anticoagulants
Fibrinolytic Agents
Thromboplastin